Company intelligence / Profile preview

Reddot Biotech

Houston, Texas, United Statesreddotbiotech.com ↗

Ownership: Private
Employees: ~24
Development stage: Commercial

Overview

Reddot Biotech is an active biotechnology supplier specializing in high-quality ELISA kits, assay kits, and antibodies for life science research. The company focuses on providing reliable products with customization options to meet diverse scientific needs. It does not develop therapeutics or diagnostics intended for direct patient care[1][2][5].

Modalities: ProteinAntibodyAssay kit (including ELISA kits)
Industry: Chemicals & Materials

Drug pipeline

2 assets

GeneExtract RD-32

Commercial

Indications: Molecular diagnostics

1 more asset in the full pipeline.

Partnerships

The company partners with global distributors to make its products accessible worldwide[1].

Beyond the preview

Go deeper on Reddot Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reddot Biotech.